Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Cash from Financing Activities (2022 - 2025)

Bioregenx has reported Cash from Financing Activities over the past 4 years, most recently at -$44143.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 535.7% year-over-year to -$44143.0; the TTM value through Dec 2025 reached $33098.0, down 92.51%, while the annual FY2025 figure was $33098.0, 92.51% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$44143.0 at Bioregenx, down from $70833.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $513370.0 in Q4 2023 and troughed at -$44143.0 in Q4 2025.
  • A 4-year average of $114700.6 and a median of $46442.0 in 2024 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: soared 14571.91% in 2023 and later plummeted 535.7% in 2025.
  • Year by year, Cash from Financing Activities stood at $3499.0 in 2022, then soared by 14571.91% to $513370.0 in 2023, then crashed by 101.35% to -$6944.0 in 2024, then plummeted by 535.7% to -$44143.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for BRGX at -$44143.0 in Q4 2025, $70833.0 in Q3 2025, and $16823.0 in Q2 2025.